Enliven Therapeutics Inc. (ELVN)

ELVN trades at $20.01, 20.0% below the near-term max pain of $25 expiring Oct 17, 2025 (18 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($2.5-$95), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ELVN shows a downward trend from 95 to 2.5, indicating bearish sentiment or hedging activity. The 308% spread signals divergent expectations across timeframes. Levels distributed around 20.01. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.